Coupling Genetic Addiction Risk Score (GARS) and Pro Dopamine Regulation (KB220) to Combat Substance Use Disorder (SUD)

Advanced Research in Gastroenterology & Hepatology
doi 10.19080/argh.2017.04.555636
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Juniper Publishers

Related search

Coupling Genetic Addiction Risk Score (GARS) With Electrotherapy: Fighting Iatrogenic Opioid Dependence

Journal of Addiction Research & Therapy
2013English

Iatrogenic Opioid Dependence Is Endemic and Legal: Genetic Addiction Risk Score (GARS) With Electrotherapy a Paradigm Shift in Pain Treatment Programs

Health
2013English

Parental History of Substance Use Disorders (SUD) and SUD in Offspring: A Controlled Family Study of Bipolar Disorder

American Journal on Addictions
MedicineClinical PsychologyPsychiatryMental Health
2014English

Dopamine Genetic Risk Score Predicts Depressive Symptoms in Healthy Adults and Adults With Depression

PLoS ONE
Multidisciplinary
2014English

Risk and Substance Use

2020English

Genetic and Environmental Risk Factors for Adolescent-Onset Substance Use Disorders

Child and Adolescent Psychiatric Clinics of North America
PsychiatryChild HealthMental HealthPediatricsPerinatology
2010English

Access to Substance Use Disorder Treatment Services in Canada

Journal of Alcoholism & Drug Dependence
2017English

Associations Between Substance Use Disorders and Suicide Mortality Risk Should Be Adjusted for Tobacco Use Disorder

Addiction
MedicinePsychiatryMental Health
2017English

Dually Diagnosed Patients' Responses to Substance Use Disorder Treatment

Journal of Substance Abuse Treatment
MedicineClinical PsychologyPsychiatryPsychiatric Mental HealthMental Health
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy